NorthCrest Asset Manangement
CTKB icon

NorthCrest Asset Manangement’s Cytek Biosciences CTKB Stock Holding History

NorthCrest Asset Manangement’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$73K Sell
13,619
-304
-2% -$1.44K ﹤0.01% 988
2026
Q2 		$63.9K Sell
13,923
-1,293
-8% -$5.52K ﹤0.01% 903
2026
Q1 		$68.9K Buy
15,216
+927
+6% +$4.38K ﹤0.01% 754
2025
Q4 		$74.4K Buy
14,289
+7
+0% +$33 ﹤0.01% 809
2025
Q3 		$54.1K Sell
14,282
-976
-6% -$3.66K ﹤0.01% 739
2025
Q2 		$57.4K Sell
15,258
-15,519
-50% -$51.7K ﹤0.01% 622
2025
Q1 		$123K Sell
30,777
-1,407
-4% -$7.29K ﹤0.01% 581
2024
Q4 		$209K Sell
32,184
-18,983
-37% -$113K 0.01% 543
2024
Q3 		$283K Buy
51,167
+17
+0% +$96 0.01% 492
2024
Q2 		$285K Hold
51,150
– – 0.01% 461
2024
Q1 		$343K Sell
51,150
-900
-2% -$7.12K 0.01% 430
2023
Q4 		$475K Hold
52,050
– – 0.02% 388
2023
Q3 		$287K Sell
52,050
-1,000
-2% -$8.02K 0.01% 445
2023
Q2 		$453K Hold
53,050
– – 0.02% 377
2023
Q1 		$488K Buy
53,050
+1,000
+2% +$10.8K 0.02% 363
2022
Q4 		$531K Buy
+52,050
New +$700K 0.03% 267

Other funds holding CTKB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

NorthCrest Asset Manangement's CTKB Position: Q3 2026 in Review

NorthCrest Asset Manangement reduced its Cytek Biosciences (CTKB) stake by 2.2% in Q3 2026, selling an estimated $1.44K and leaving 13,619 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

NorthCrest Asset Manangement first reported a position in CTKB in Q4 2022 and has held it in 16 quarters since. The position peaked at $531K in Q4 2022. 65 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • NorthCrest Asset Manangement held 13,619 shares of Cytek Biosciences worth $73K as of Q3 2026.
  • NorthCrest Asset Manangement sold 304 Cytek Biosciences shares in Q3 2026, an estimated $1.44K.
  • Cytek Biosciences made up ﹤0.01% of NorthCrest Asset Manangement's portfolio in Q3 2026, its #988 holding.
  • NorthCrest Asset Manangement first reported a position in Cytek Biosciences in Q4 2022 and has held it in 16 quarters since.
  • NorthCrest Asset Manangement's Cytek Biosciences position peaked at $531K in Q4 2022.
  • 65 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.